Patients with moderate and high ESSDAI scores exhibited significantly higher US activity (p = 0.006), were more frequently positive for anti-SSA (p = 0.014) and had more common lymphoma (p = 0.043) in comparison to those of SS patients with low ESSDAI scores. Here, CALR is linked to synovial sarcoma.